HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Torrelo Selected Research

Therapeutics

1/2022Infliximab is an appropriate second-line therapy in infants with steroid refractory pyoderma gangrenosum.
5/2018Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I.
6/2014Patient perspectives on triggers, adherence to medical recommendations, and disease control in atopic dermatitis: the DATOP study.
6/2013Health-related quality of life, patient satisfaction, and adherence to treatment in patients with moderate or severe atopic dermatitis on maintenance therapy: the CONDA-SAT study.
11/2006Treatment of patients with atopic dermatitis using wet-wrap dressings with diluted steroids and/or emollients. An expert panel's opinion and review of the literature.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Torrelo Research Topics

Disease

9Atopic Dermatitis (Atopic Eczema)
02/2021 - 11/2006
3Neoplasms (Cancer)
02/2021 - 07/2011
2Skin Diseases (Skin Disease)
06/2021 - 03/2016
2Pruritus (Itching)
05/2018 - 11/2006
2Eczema
11/2012 - 11/2012
1Pyoderma Gangrenosum
01/2022
1Hypersensitivity (Allergy)
06/2021
1Tuberculosis (Tuberculoses)
02/2021
1Hypopigmentation (Hypomelanosis)
11/2020
1Hamartoma
11/2020
1Lipomatosis
11/2020
1Lymphedema (Milroy Disease)
11/2020
1Tuberous Sclerosis (Bourneville's Disease)
11/2020
1Arteriovenous Malformations (Arteriovenous Malformation)
10/2020
1Capillary Malformation-Arteriovenous Malformation
10/2020
1Neutropenia
12/2019
1Lymphopenia (Lymphocytopenia)
12/2019
1Ichthyosis (Xeroderma)
10/2018
1Xeroderma Pigmentosum (Kaposi's Disease)
07/2018
1Leukocytosis (Pleocytosis)
03/2017
1Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris)
03/2015
1Cutaneous Mastocytosis
06/2012
1Urticaria Pigmentosa
06/2012
1Mastocytosis
06/2012
1Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara)
09/2011
1Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa)
01/2010
1Cicatrix (Scar)
01/2010
1Epidermolysis Bullosa
01/2010
1X-Linked Ichthyosis (Ichthyosis, X Linked)
01/2010
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2007
1Dermatitis
11/2006
1Nevus (Nevi)
07/2006

Drug/Important Bio-Agent (IBA)

3CollagenIBA
11/2020 - 07/2006
2SteroidsIBA
01/2022 - 11/2006
2Proteins (Proteins, Gene)FDA Link
10/2020 - 07/2011
2Steryl-Sulfatase (Steroid Sulfatase)IBA
10/2018 - 01/2010
2EnzymesIBA
10/2018 - 03/2017
2methylprednisolone aceponateIBA
11/2012 - 11/2012
2EmollientsIBA
11/2012 - 11/2006
1Infliximab (Remicade)FDA Link
01/2022
1COVID-19 VaccinesIBA
06/2021
1Pharmaceutical PreparationsIBA
02/2021
1baricitinibIBA
02/2021
1Janus KinasesIBA
02/2021
1Biological ProductsIBA
01/2020
1Immunoglobulins (Immunoglobulin)IBA
12/2019
1Azathioprine (Imuran)FDA LinkGeneric
04/2019
1Imiquimod (Aldara)FDA LinkGeneric
07/2018
1AntipruriticsIBA
05/2018
1Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2017
1Immunosuppressive Agents (Immunosuppressants)IBA
05/2017
1Acute-Phase Proteins (Acute-Phase Protein)IBA
03/2017
1hydrocortisone 17-butyrate 21-propionateFDA Link
03/2016
1Filaggrin ProteinsIBA
03/2015
1Biomarkers (Surrogate Marker)IBA
06/2012
1Tryptases (Tryptase)IBA
06/2012
1Keratins (Keratin)IBA
09/2011
1Tacrolimus (Prograf)FDA LinkGeneric
02/2008

Therapy/Procedure

5Therapeutics
01/2022 - 11/2006
1Emergency Treatment
06/2012
1Drug Therapy (Chemotherapy)
05/2007